Vir Biotechnology Financial Ratios
NASDAQ: VIRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vir Biotechnology ratio analysis
Vir Biotechnology earned a net margin of -638.9% in FY 2025, up from -703.4% a year earlier. Gross margin was 100.0% compared with a median of 97.8% over the prior 6 years. Return on equity reached -57.2%, meaning Vir Biotechnology generated -0.57 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Vir Biotechnology financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | 6.61 | 10.57 | — | — | — | — |
| Price / sales | 12.00 | 13.77 | 15.66 | 2.08 | 4.96 | 41.79 | 45.16 | — | — |
| Price / book | 1.08 | 0.89 | 0.85 | 1.62 | 3.80 | 4.45 | 0.86 | — | — |
| Gross margin | 100.0% | 98.9% | 96.8% | 90.9% | 94.0% | 100.0% | 100.0% | — | — |
| Operating margin | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% | -388.9% | -2,199.7% | -1,112.6% | -3,009.5% |
| Net margin | -638.9% | -703.4% | -713.7% | 31.9% | 48.3% | -391.1% | -2,159.0% | -1,086.3% | -2,579.5% |
| Free cash flow margin | -578.5% | -611.4% | -928.7% | 98.7% | -6.3% | -258.6% | -1,712.7% | -958.8% | -2,552.5% |
| Return on equity (ROE) | -57.2% | -45.4% | -38.7% | 24.8% | 36.9% | -41.7% | -41.2% | — | — |
| Return on assets (ROA) | -43.7% | -37.3% | -32.1% | 18.4% | 27.0% | -32.5% | -34.1% | -60.5% | — |
| Current ratio | 5.54 | 8.71 | 9.05 | 4.93 | 4.58 | 7.80 | 6.81 | 2.95 | — |
| Revenue growth | -7.6% | -13.9% | -94.7% | 47.5% | 1,334.4% | 843.9% | -24.2% | 293.9% | — |
| EPS growth | — | — | -219.8% | -3.3% | — | — | — | — | — |